Theranostics, 2021 · DOI: 10.7150/thno.49054 · Published: February 20, 2021
Spinal cord injury (SCI) can lead to permanent paralysis due to a primary injury followed by secondary injury events like inflammation and cell death. Axonal degeneration, where nerve fibers break down, is a key feature of SCI. The protein SARM1 has been identified as a key mediator of Wallerian degeneration (WD), a programmed self-destruction process that promotes axon breakdown. However, its specific functions after SCI are not well understood. This study found that SARM1 is upregulated in neurons and astrocytes after SCI. Deleting SARM1 in these cells promoted nerve regeneration and reduced inflammation, suggesting that inhibiting SARM1 could be a potential treatment for SCI.
SARM1 may be a potential therapeutic target for treating spinal cord injury.
Inhibitors of the SARM1 signaling pathway, such as FK866, could be developed as drugs to treat SCI.
Reducing neuroinflammation by targeting SARM1 may improve outcomes after SCI.